Martin Kolb
Martin Kolb
Professor of Medicine, McMaster University Hamilton
Email verificata su mcmaster.ca
TitoloCitata daAnno
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
L Richeldi, RM Du Bois, G Raghu, A Azuma, KK Brown, U Costabel, ...
New England Journal of Medicine 370 (22), 2071-2082, 2014
20022014
Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis
M Kolb, PJ Margetts, DC Anthony, F Pitossi, J Gauldie
The Journal of clinical investigation 107 (12), 1529-1536, 2001
6652001
The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
A Moeller, K Ask, D Warburton, J Gauldie, M Kolb
The international journal of biochemistry & cell biology 40 (3), 362-382, 2008
6512008
Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis
A Moeller, SE Gilpin, K Ask, G Cox, D Cook, J Gauldie, PJ Margetts, ...
American journal of respiratory and critical care medicine 179 (7), 588-594, 2009
4812009
Smad3 null mice develop airspace enlargement and are resistant to TGF-β-mediated pulmonary fibrosis
P Bonniaud, M Kolb, T Galt, J Robertson, C Robbins, M Stampfli, C Lavery, ...
The Journal of Immunology 173 (3), 2099-2108, 2004
3862004
Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report
HR Collard, CJ Ryerson, TJ Corte, G Jenkins, Y Kondoh, DJ Lederer, ...
American journal of respiratory and critical care medicine 194 (3), 265-275, 2016
3752016
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
L Wollin, E Wex, A Pautsch, G Schnapp, KE Hostettler, S Stowasser, ...
European Respiratory Journal 45 (5), 1434-1445, 2015
2742015
TGF-β and Smad3 signaling link inflammation to chronic fibrogenesis
P Bonniaud, PJ Margetts, K Ask, K Flanders, J Gauldie, M Kolb
The Journal of Immunology 175 (8), 5390-5395, 2005
2702005
Progressive transforming growth factor β1–induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor
P Bonniaud, PJ Margetts, M Kolb, JA Schroeder, AM Kapoun, D Damm, ...
American journal of respiratory and critical care medicine 171 (8), 889-898, 2005
2672005
Gene transfer of transforming growth factor-β1 to the rat peritoneum: effects on membrane function
PJ Margetts, M Kolb, T Galt, CM Hoff, TR Shockley, J Gauldie
Journal of the American Society of Nephrology 12 (10), 2029-2039, 2001
2662001
Proteoglycans decorin and biglycan differentially modulate TGF-β-mediated fibrotic responses in the lung
M Kolb, PJ Margetts, PJ Sime, J Gauldie
American Journal of Physiology-Lung Cellular and Molecular Physiology 280 (6…, 2001
2452001
Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin
M Kolb, PJ Margetts, T Galt, PJ Sime, Z Xing, M Schmidt, J Gauldie
American journal of respiratory and critical care medicine 163 (3), 770-777, 2001
2232001
TGF-β, Smad3 and the process of progressive fibrosis
J Gauldie, P Bonniaud, P Sime, K Ask, M Kolb
Biochemical society transactions 35 (4), 661-664, 2007
2092007
Re-evaluation of fibrogenic cytokines in lung fibrosis
M Kelly, M Kolb, P Bonniaud, J Gauldie
Current pharmaceutical design 9 (1), 39-49, 2003
2002003
VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats
L Farkas, D Farkas, K Ask, A Mller, J Gauldie, P Margetts, M Inman, ...
The Journal of clinical investigation 119 (5), 1298-1311, 2009
1832009
Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum
PJ Margetts, M Kolb, L Yu, CM Hoff, CJ Holmes, DC Anthony, J Gauldie
The American journal of pathology 160 (6), 2285-2294, 2002
1742002
Differences in the fibrogenic response after transfer of active transforming growth factor-β 1 gene to lungs of “fibrosis-prone” and “fibrosis-resistant” mouse strains
M Kolb, P Bonniaud, T Galt, PJ Sime, MM Kelly, PJ Margetts, J Gauldie
American journal of respiratory cell and molecular biology 27 (2), 141-150, 2002
1722002
Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors
L Farkas, J Gauldie, NF Voelkel, M Kolb
American journal of respiratory cell and molecular biology 45 (1), 1-15, 2011
1622011
Connective tissue growth factor is crucial to inducing a profibrotic environment in “fibrosis-resistant” BALB/c mouse lungs
P Bonniaud, G Martin, PJ Margetts, K Ask, J Robertson, J Gauldie, M Kolb
American journal of respiratory cell and molecular biology 31 (5), 510-516, 2004
1592004
Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats
PJ Margetts, S Gyorffy, M Kolb, L Yu, CM Hoff, CJ Holmes, J Gauldie
Journal of the American Society of Nephrology 13 (3), 721-728, 2002
1592002
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20